Management of atrial fibrillation in patients with heart failure.
@article{Neuberger2007ManagementOA,
title={Management of atrial fibrillation in patients with heart failure.},
author={H R Neuberger and Christian Mewis and Dirk J van Veldhuisen and Ulrich Schotten and Isabelle C. Van Gelder and Maurits A. Allessie and Michael B{\"o}hm},
journal={European heart journal},
year={2007},
volume={28 21},
pages={
2568-77
}
}Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in patients with CHF. This review summarizes current literature concerning the following topics: (i) prognostic relevance of AF in patients with CHF, (ii) relevance and strategies of rhythm and rate control in patients with AF and CHF, and (iii) options for prevention of AF in patients with ventricular…
35 Citations
Managing patients with rapid atrial fibrillation and decompensated heart failure.
- MedicineCirculation. Heart failure
- 2009
It appears that there is no net benefit of a routine strategy to pursue sinus rhythm in patients with AF and heart failure, and the use of these therapies should be switched off.
Ventricular rate control of atrial fibrillation in heart failure.
- MedicineHeart failure clinics
- 2013
β-Blockers in Atrial Fibrillation Patients With or Without Heart FailureCLINICAL PERSPECTIVE
- Medicine
- 2016
In this large nationwide cohort study, evidence of a lower mortality with β-blocker therapy in AF patients with concomitant HF was observed and indications that β- blocker treatment is also associated with a better prognosis inAF patients without conComitant HF are observed.
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions
- Medicine, BiologyHeart Failure Reviews
- 2021
The current manuscript aims to review the existing literature regarding the underlying pathophysiology, to present the novel trends of treatment, and to predict the future perspective of these two linked diseases with the numerous unanswered questions.
Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
- MedicineEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
- 2008
Failure to CRT is associated with new-onset AF, and total atrial activation time may be a parameter to predict response in AF patients.
[Hundred years of atrial fibrillation: current knowledge and perspectives].
- MedicineSrpski arhiv za celokupno lekarstvo
- 2010
There is a clear scientific proof that rhythm control offers no benefit over frequency control, at least for older patients, even with advanced left ventricular dysfunction, and optimal treatment for younger, highly symptomatic, otherwise healthy AF patients has not been designed.
Should aldosterone blockade be used beyond current indications in heart failure?
- Medicine, BiologyCurrent heart failure reports
- 2009
It is hoped that the results of large randomized clinical trials further elucidate the indications of ARAs beyond current guidelines and inspire new ideas on how to best treat congestive heart failure.
Is atrial fibrillation associated with poor outcome after thrombolysis?
- Medicine, PsychologyJournal of Neurology
- 2010
Patients with AF had significantly worse 90-day clinical outcome after IVT compared to those without AF, probably due to more severe baseline neurological deficits and the greater number of arterial occlusions in the MRA before IVT.
References
SHOWING 1-10 OF 115 REFERENCES
Impact of atrial fibrillation on mortality in patients with chronic heart failure.
- MedicineEuropean journal of heart failure
- 2002
Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.
- MedicineEuropean heart journal
- 2000
The present data do not support the concept that the presence, or the development of atrial fibrillation in patients with advanced chronic heart failure is independently related to an adverse outcome during long-term follow-up.
Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure
- MedicineCirculation
- 2006
Although CRT did not reduce the incidence of AF, CRT improved the outcome regardless of whether AF developed, and the effect of cardiac resynchronization therapy on the outcome and efficacy of CRT was evaluated.
Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
- MedicineAmerican heart journal
- 2002
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.
- Medicine, BiologyThe American journal of cardiology
- 2003
Improving survival for patients with atrial fibrillation and advanced heart failure.
- MedicineJournal of the American College of Cardiology
- 1996
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials
- MedicineCirculation
- 2003
Treatment with the ACEi enalapril markedly reduces the risk of development of atrial fibrillation in patients with left ventricular dysfunction.
Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.
- MedicineCirculation
- 1998
In patients with CHF, amiodarone has a significant potential to spontaneously convert patients in AF to sinus rhythm, with patients who convert having a lower mortality rate than those who do not, and the drug prevented the development of new-onset AF and significantly reduced the VR in those with persistent AF.
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
- MedicineJournal of the American College of Cardiology
- 2006
The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies
- MedicineCirculation
- 1993
Atrial fibrillation does not increase major morbidity or mortality in mild to moderate heart failure and hospitalization rate for heart failure was not increased in either study.




